Syapse

Excited to share our new study from the Journal of Personalized Medicine showing how Syapse’s real-world data links personalized medicine (PM) adoption to better cancer care outcomes, including targeted therapies and clinical trial enrollment. Read more: tinyurl.com/3m4df8jc

New manuscript "Evaluation of real-world tumor response derived from electronic health record data sources: A feasibility analysis in mNSCLC patients treated with chemotherapy” shows the feasibility of aligning RWD data to evaluate rw-response to treatment bit.ly/3LGcdqS

Join Dr. Thomas Brown, CMO of Syapse, next week at the DIA RWE Conference! He will be representing the RWE Alliance, of which Syapse is a founding member, to discuss the FDA's framework for advancing RWE programs, and the path for future development. tinyurl.com/bdh2ynam

Our Sandbox platform offers a scalable and flexible interface that empowers researchers to harness the power of Syapse’s research-ready Analytic Datasets in #lung, #breast, #ovarian and #bladder cancers. Save 90% of your time, request a demo today. hubs.ly/Q024nbs80

Up next in our Experts in Technology podcast series – part 2 with Patricia Thaine from @Private_AI and @VinDNA. How do we hold one another accountable for putting patient privacy first? Hear what our expert has to say: hubs.ly/Q020Jymr0 #AIforHealthcare #PrivacyMatters

Read our take on the latest breaking news from @NCRAnews! From Certified Tumor Registrar to Oncology Data Specialist: The future of tech-enabled data curation in the fight against cancer linkedin.com/pulse/from-cer…

Privacy in #AI is not a novel concept, yet at times it is an afterthought. Next up in our series, @VinDNA interviews @PrivateNLP, CEO and Co-founder of @_PrivateAI to discuss the importance of prioritizing privacy in your planning. hubs.ly/Q01-Rqqh0

Meet Rayna, Associate Director of Epidemiology at @Syapse! Rayna supported her father through bladder cancer up until the end of his life and felt called to join us in our mission. You can learn more about Rayna here: hubs.ly/Q01-S1340

Is it possible to reduce the time to generate life-saving #insights by 90%? It is with Syapse Cohorts enhanced by Analytical Datasets (ADS), launching next week. Using Syapse data, researchers will have access to a research-ready dataset in bladder, lung, breast, and ovarian!

Listen to part two of our Experts in Technology #podcast with @SeanKhozin! hubs.ly/Q01ZPW1p0

Join Sean Khozin and Vinod Subramanian in a two-part conversation on the mind-blowing progress made in #healthtech over the last few decades. They'll also discuss #rwd, #AI, and more that can help physicians become true healers once again! hubs.ly/Q01YWVqW0

Join us in recognizing #BlackFamCan! We're committed to helping close healthcare disparity gaps by using comprehensive cancer patient data and analytics. Learn how we've identified racial disparities in BRCA testing for TNBC patients: hubs.ly/Q01TF8th0

Cancer progression detection is challenging, especially for early-stage diseases. Our #ASCO2023 abstract helps address this by developing a deep-learning approach to accurately identify metastatic status using #RWD from #EHRs. Dive into the work: hubs.ly/Q01Ssxxb0

More people than ever are winning the fight against cancer. Today, on #NCSD2023, we #CelebrateLife! At Syapse, we're proud to offer data, tech, and research solutions that help health systems and life sciences create answers that reduce the fear and burden of this disease.

AI and clinical-genomic data are revolutionizing the fight against cancer. Join us this week at #ASCO23 to learn how our AI-driven analytics solutions help health systems and life sciences achieve their precision medicine goals. Book time with us: hubs.ly/Q01RGMV50

We’re thrilled to have co-authored this research with @bmsnews that’ll be presented at #ASCO23, creating a better understanding of treatment outcomes for patients with LR-MDS treated with ESAs. Attend this presentation and meet with us to learn more: hubs.ly/Q01QSw-40

Today, we raise awareness for #ClinicalTrialsDay and the work that clinical research teams do to improve patients' lives and fight cancer. Thank you to these teams across our health system and life sciences partnerships for all you do to reduce the fear and burden of cancer.

We’re honored to have collaborated with @CancerResrch on the challenging work of using #RWD to assess tumor response. This research is key to improving care and using RWD for regulatory purposes. Attend this poster session and meet with us at #ASCO23: hubs.ly/Q01Qnf1z0

Our comprehensive brain cancer data can power the discovery of answers to crucial questions including population characteristics, benign & malignant brain tumor behavior, biomarker testing rates including genes MGMT & IDH1, therapies prescribed, clinical outcomes, & more.

We #GoGrayinMay to raise awareness for #BTAM to help propel research and treatments forward. At Syapse, we offer comprehensive #RWD that can help power the discovery of answers to crucial questions about brain cancer. Together, let's reduce the fear and burden of this disease.